Published on: November 1, 2015
by Megan Brooks for Medscape:
A new study provides evidence for the first time of a causal relationship between telomere length (TL) and Alzheimer’s disease (AD), say investigators from Sweden.
“This is the first study addressing the causal effect of TL on AD,” principal investigator Sara Hägg, PhD, docent of molecular epidemiology, Karolinska Institutet, Stockholm, told Medscape Medical News.
Telomeres are repetitive DNA sequences at the ends of chromosomes that progressively shorten with age. Observational studies suggest that shorter telomeres are associated with shorter life expectancy and greater risk for age-related diseases, including AD. However, these studies could have residual confounding or reverse causation, making it difficult to draw conclusions on whether TL is causally associated with AD.
Dr Hägg and colleagues investigated the causal effect of TL on AD by applying instrumental variable analysis and Mendelian randomization methods to genome-wide association study (GWAS) data.
The Mendelian randomization analysis “has the advantage of being independent of any measured or unmeasured confounders by using genetic variants” as instrumental variables, the authors explain in a Research Letter in the October issue of JAMA Neurology.
They report that a genetic risk score for TL, including 7 single-nucleotide polymorphisms (SNPs) known to be involved in TL and AD, was significantly associated with shorter telomeres and higher risk for AD (odds ratio [OR], 1.02 for per TL-decreasing allele).
Shorter TL was causally associated with a higher risk for AD (OR, 1.36 per SD decrease of TL; P = .002), Dr Hägg and colleagues report. They “roughly estimate” that 1 SD decrease in TL to be equal to an attrition rate of 1226 TL base pairs in 40 to 60 years, “corresponding to a 36% higher risk for AD.”
“We knew there was an association (between TL and AD), but most researchers did not think telomeres were involved in the actual mechanism itself but rather a biomarker of the underlying pathological process,” Dr Hägg told Medscape Medical News. “There is an ongoing discussion in the field concerning the cause or consequence of telomeres in aging related diseases. This paper adds information in this regards,” she said.
“The effects are small,” she noted, “and one cannot measure the lengths of the telomeres and know the individual biological age. There are in fact companies in the US offering this service, which I think is questionable. However, increasing knowledge of how the mechanisms for disease works is always promising for future therapeutics,” Dr Hägg said.
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.